Delayed Submission of MDS Assessment
Summary
The facility failed to ensure the timely submission of the Minimum Data Set (MDS) assessment for one resident, identified as R49. This deficiency was identified through staff interviews and record reviews. R49 was admitted to the facility with multiple diagnoses, including chronic kidney disease stage 5, type 2 diabetes, and chronic obstructive pulmonary disease, among others. The resident's medication regimen included atorvastatin, Breo Ellipta, buspirone, clopidogrel, gabapentin, hydroxyzine, pantoprazole, paricalcitol, and paroxetine Hcl. The last completed Quarterly MDS assessment for R49 was dated 10/10/2024, and the subsequent assessment was still in progress at the time of the survey. The MDS Coordinator, who was responsible for completing the assessments, confirmed that R49's Quarterly assessment was completed on 1/24/2025 but was rejected on 2/3/2025 due to missing information in Section O (therapy). The assessment was being corrected, but there were issues with inputting the information due to a transition into a new system. The Director of Health Services (DHS) confirmed that the Quarterly MDS assessment for R49 was not completed within the required timeframe. The DHS expected the MDS assessments to be completed and processed timely, and if there were concerns with transmission or completion, the MDS Coordinator was expected to seek assistance from the DHS or the corporate liaison.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release October 8, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.